Cullinan Therapeutics, Inc.

Nuveen, LLC CGEM
Report date
3/31/2026
Quarter
2026 Q1
Filed
4/30/2026
Shares
805,700
Value ($000)
11,449
Weight
0.0%
2025 Q1 - 2026 Q1 (5 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).